Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.

Pelosof L, Yerram S, Armstrong T, Chu N, Danilova L, Yanagisawa B, Hidalgo M, Azad N, Herman JG.

Epigenetics. 2017 Jul 3;12(7):540-550. doi: 10.1080/15592294.2016.1265711. Epub 2016 Dec 5.

2.

Translating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity.

Yanagisawa B, Ghiaur G, Smith BD, Jones RJ.

Exp Hematol. 2016 Dec;44(12):1130-1137. doi: 10.1016/j.exphem.2016.08.010. Epub 2016 Sep 28. Review.

3.

Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes.

Gerber JM, Zeidner JF, Morse S, Blackford AL, Perkins B, Yanagisawa B, Zhang H, Morsberger L, Karp J, Ning Y, Gocke CD, Rosner GL, Smith BD, Jones RJ.

Haematologica. 2016 May;101(5):607-16. doi: 10.3324/haematol.2015.135194. Epub 2016 Jan 27.

4.

Hitting the bull's eye: targeting HMGA1 in cancer stem cells.

Yanagisawa BL, Resar LM.

Expert Rev Anticancer Ther. 2014 Jan;14(1):23-30. doi: 10.1586/14737140.2013.859988.

Supplemental Content

Loading ...
Support Center